Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report
This note presents the factual context of the 23 April 2026 share price move, provides a concise overview of Tissue Repair Ltd's business, outlines the likely and plausible drivers of the move (in the absence of a specific company-issued announcement identifiable on the day), …
This note presents the factual context of the 23 April 2026 share price move, provides a concise overview of Advanced Innergy Holdings Limited's business, outlines the likely and plausible drivers of the move (in the absence of a specific company-issued announcement identifiable on the …
Cambium Bio Ltd (ASX:CMB) declined sharply on Thursday even as the company released what some investors may interpret as a strategically significant regulatory update. The stock’s weakness came alongside confirmation from the U.S. Food and Drug Administration that a single adequate and well-controlled pivotal …
BPH Global Ltd (ASX:BO8) continues to trade at the lower end of the ASX micro-cap spectrum, with its share price holding steady at A$0.002 as of April 23, 2026. The absence of price movement during the latest session, combined with very low trading volume …
Regis Healthcare Ltd is one of Australia's leading residential aged-care operators, providing accommodation and support services for more than 10,000 older Australians. The company's service footprint spans residential aged care, home care, day therapy, respite services and retirement villages, giving it one of the …
Intelicare Holdings Ltd (ASX:ICR) shares rose 12.04% to AUD 0.026 during the morning session on 23 April 2026, with the upward movement following the release of a new commercial update involving a partnership with Warrigal Care Limited. The stock has also recorded a notable …
Noxopharm Limited (ASX:NOX) shares concluded the trading session on 22 April 2026 at AUD 0.066, remaining flat for the day. While the stock touched an intraday high of AUD 0.070, but the selling pressure emerged and pushed the stock downward pressure. NOX also remains …
Global Health ASX stock occupies a specialised niche of the health technology sector, distinct from the larger, more capitalised healthcare names on the ASX. Recent performance of ASX GLH has reflected the slow-but-steady nature of enterprise-software adoption in healthcare — longer sales cycles, sticky …
Alterity Therapeutics Ltd declined 9.09% to AUD 0.010 on 22 April 2026, even as the company presented new analyses from its Phase 2 clinical trial of ATH434. The data was shared during a Late Breaking Science Session at the American Academy of Neurology Annual …
Nyrada Inc recorded a modest decline of 1.65% to AUD 0.60 on 22 April 2026, even as the company announced a key milestone in its clinical development program. The activation of the first site in its PROTECT-MI Phase IIa trial marks the transition from …
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…